Xention Siphons Off OAB Therapy Into New Spin Out, Provesica
Atrial fibrillation will be Xention's focus following the spin-out of its overactive bladder assets into a new company, Provesica
Atrial fibrillation will be Xention's focus following the spin-out of its overactive bladder assets into a new company, Provesica